Page last updated: 2024-09-05

erlotinib hydrochloride and Dermatomyositis

erlotinib hydrochloride has been researched along with Dermatomyositis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chauhan, S; Gupta, M; Gupta, MK; Kesari, AA; Madabhavi, I; Rastogi, M; Revannasiddaiah, S; Seam, RK	1

Other Studies

1 other study(ies) available for erlotinib hydrochloride and Dermatomyositis

Article	Year
Dermatomyositis and chest radiography leading to the diagnosis of lung cancer and subsequent confusions in staging due to the presence of tuberculosis. BMJ case reports, 2012, Apr-02, Volume: 2012 Topics: Aged; Antitubercular Agents; Dermatomyositis; Diagnosis, Differential; Erlotinib Hydrochloride; Humans; Lung Neoplasms; Male; Neoplasm Staging; Protein Kinase Inhibitors; Quinazolines; Radiography, Thoracic; Tomography, X-Ray Computed; Tuberculosis, Pulmonary	2012

Article

Year

Dermatomyositis and chest radiography leading to the diagnosis of lung cancer and subsequent confusions in staging due to the presence of tuberculosis.

BMJ case reports, 2012, Apr-02, Volume: 2012

Topics: Aged; Antitubercular Agents; Dermatomyositis; Diagnosis, Differential; Erlotinib Hydrochloride; Humans; Lung Neoplasms; Male; Neoplasm Staging; Protein Kinase Inhibitors; Quinazolines; Radiography, Thoracic; Tomography, X-Ray Computed; Tuberculosis, Pulmonary

2012